Merck
MRK
$127.00
Share price
0.09%
Change (1 day)
9.54%
Change (1 year)
Categories
EPS for Merck (MRK)
EPS in 2023 (TTM): $1.82
According to Merck's latest financial reports the company's current EPS (TTM) is $1.82. In 2022 the company made an earnings per share (EPS) of $5.73 an increase over its 2021 EPS that were of $5.17.
EPS history for Merck from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.82 | -68.21% |
| 2022 | $5.73 | 10.92% |
| 2021 | $5.17 | 84.68% |
| 2020 | $2.80 | -27.2% |
| 2019 | $3.84 | 63.44% |
| 2018 | $2.35 | 151.11% |
| 2017 | $0.94 | -54.58% |
| 2016 | $2.06 | 30.21% |
| 2015 | $1.58 | -61.99% |
| 2014 | $4.16 | 180.51% |
| 2013 | $1.48 | -31.82% |
| 2012 | $2.18 | 6.62% |
| 2011 | $2.04 | 626.78% |
| 2010 | $0.28 | -95.05% |
| 2009 | $5.68 | 56.36% |
| 2008 | $3.63 | -449.04% |
| 2007 | -$1.04 | -150.98% |
| 2006 | $2.04 | -3.32% |
| 2005 | $2.11 | -20.08% |
| 2004 | $2.64 | -10.81% |
| 2003 | $2.96 | -6.92% |
| 2002 | $3.18 | 0% |
| 2001 | $3.18 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 673.20% | 🇺🇸 USA |
 Novartis NVS | $3.74 | 105.30% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | 2.10% | 🇺🇸 USA |
 Abbott Laboratories ABT | $2.97 | 63.16% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 198.04% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | 676.76% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | 74.58% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $3.97 | 117.93% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | 92.17% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.00 | -209.79% | 🇮🇱 Israel |